Amadeus Integrates IBM Digital Health Pass Into Its Digital Health Verification Technology

IBMIBM (NYSE: IBM) and Amadeus (MCE: AMS) announced that they are working together to help meet one of the major challenges facing travel companies today: checking and validating the COVID-19 health documentation of travelers at checkpoints where required.

As part of that effort, IBM Digital Health Pass is now integrated into Traveler ID for Safe Travel, Amadeus' digital health verification solution. This enables airlines to integrate the use of COVID-19 digital health credentials into their existing reservation and booking system, allowing airline passengers the option to scan or upload documentation to show their health credentials.

As passengers move through the online check-in process, Traveler ID for Safe Travel checks the requirements for that particular trip against destination country regulations. This then prompts passengers with the option to generate a secure COVID-19 digital credential by scanning paper documents or uploading a digital version from their mobile or desktop.

These COVID-19 digital health credentials are then verified using IBM Digital Health Pass, which uses a combination of encryption and blockchain technologies to authenticate COVID-19 health credentials against a global ecosystem of labs, vaccination centers and healthcare providers. Airlines receive a simple status confirming a passenger is ready to fly. This secure approach provides passenger privacy since only the compliance with border entry requirements is confirmed; no personal health information is stored by the airline, IBM, or Amadeus.

"While countries across the globe are beginning to slowly reopen borders to welcome back visitors, specific border entry requirements may vary greatly country to country. The need to check COVID-19 health documentation is causing significant delays during the journey for airlines and other travel providers, as well as the traveler," said Greg Land, Travel and Transportation Industry Lead, IBM. "The integration of IBM Digital Health Pass into Amadeus' Traveler ID for Safe Travel is designed to provide airlines with open technologies they can build into existing digital solutions. This can help airlines safely meet border entry requirements while delivering a smoother customer experience."

"The integration with IBM is a step-change for Traveler ID for Safe Travel. The combination of the IBM Digital Health Pass with our Traveler ID for Safe Travel technology means that COVID-19 health documents can be digitized and read, verified, and authenticated. This avoids cumbersome and time-consuming checks while traveling, and adds further reassurance to airlines and their passengers," said Christian Warneck, VP Safe Travel Ecosystem, Amadeus. "This is another milestone in the collaboration we are driving through our Safe Travel Ecosystem. By working hand in hand with customers and partners such as IBM, we can deliver the capabilities needed by travel providers and travelers to help provide a smooth passenger journey once more."

Traveler ID for Safe Travel is currently live with multiple airlines, with additional airline customers to be announced soon. Traveler ID's digital identity and health verification capabilities are also relevant for other customer groups, including hotels and airports.

About IBM

For more information about IBM visit, www.ibm.com.

About Amadeus

Travel powers progress. Amadeus powers travel. Amadeus' solutions connect travelers to the journeys they want through travel agents, search engines, tour operators, airlines, airports, hotels, cars and railways. We have developed our technology in partnership with the travel industry for over 30 years. We combine a deep understanding of how people travel with the ability to design and deliver the most complex, trusted, critical systems our customers need. We help connect over 1.6 billion people a year to local travel providers in over 190 countries. We are one company, with a global mindset and a local presence wherever our customers need us. Our purpose is to shape the future of travel. We are passionate in our pursuit of better technology that makes better journeys.

Amadeus is an IBEX 35 company, listed on the Spanish Stock Exchange under AMS.MC. The company is also part of the EuroStoxx50 and has been recognized by the Dow Jones Sustainability Index for the last eight years.

To find out more about Amadeus, visit www.amadeus.com.

Most Popular Now

AI Tool Helps Predict Relapse of Pediatr…

Artificial intelligence (AI) shows tremendous promise for analyzing vast medical imaging datasets and identifying patterns that may be missed by human observers. AI-assisted interpretation of brain scans may help improve...

Detecting Lung Cancer 4 Months Earlier a…

GPs may soon be able to identify patients with an increased risk of lung cancer up to 4 months earlier than is currently the case. The GP should be able...

Infectious Disease Surveillance Platform…

The Biothreats Emergence, Analysis and Communications Network (BEACON) leverages advanced artificial intelligence (AI), large language models (LLMs) and a network of globally based experts to rapidly collect, analyze, and disseminate...

Children's Health Ireland to Transf…

Healthcare teams responsible for paediatric care in Ireland are to save significant time in accessing important diagnostic imaging and reports, with the help of a new agreement with medical imaging...

NHS, Councils, and Housing could Share N…

A new technology partnership formally announced, could help NHS, local government, and housing organisations collaborate to create an unprecedented understanding of the risks and needs of people in their care...

AI-Powered Analysis of Stent Healing

Each year, more than three million people worldwide are treated with stents to open blocked blood vessels caused by heart disease. However, monitoring the healing process after implantation remains a...

Right Patient, Right Dose, Right Time

While artificial intelligence (AI) has shown promising potential, much of its use has remained theoretical or retrospective. Turning its potential into real-world healthcare outcomes, researchers at the Yong Loo Lin...

An AI Tool Grounded in Evidence-Based Me…

A powerful clinical artificial intelligence tool developed by University at Buffalo biomedical informatics researchers has demonstrated remarkable accuracy on all three parts of the United States Medical Licensing Exam (Step...

AXREM and BHTA Name Highland as 'Fu…

Hosted by trade associations AXREM and the British Healthcare Trades Association (BHTA), 'The Future of MedTech - Innovating for Tomorrow', will allow delegates to engage with speakers from the government...